# US 2024/0392265 A1 · Thermostable b-family dna polymerase mutant and application thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0392265 A1
- Document ID: US20240392265A1
- Status: Published application
- Kind: A1
- Application number: 18/564,400
- Filed: 2021-09-08
- Published: 2024-11-28
- Earliest claimed: 2021-05-26
- Assignees: Bgi Shenzhen
- Applicants: Bgi Shenzhen
- Inventors: Lili Zhai; Qingqing Xie; Ruyin Cao; Yue Zheng; Yuliang Dong; Wenwei Zhang; Xun Xu; Zhuo Chen
- Web page: https://patentgrep.com/patent/US20240392265A1

## CPC

- C12N 9/1252: {DNA-directed DNA polymerase (2.7.7.7), i.e. DNA replicase}
- C12Q 1/6806: Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay (C12Q1/6804 takes precedence)
- C12Q 1/6869: Methods for sequencing
- C12Y 207/07007: DNA-directed DNA polymerase (2.7.7.7), i.e. DNA replicase
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Y: ENZYMES

## Abstract

Provided are a thermostable B-family DNA polymerase mutant and an application thereof. The thermostable B-family DNA polymerase mutant is provided to mutate amino acid residues in at least two of three sites of group A, i.e., 408, 409, and 410 in an amino acid sequence of thermostable B-family DNA polymerases to obtain proteins having DNA polymerase activity. A-group sites (408/409/410), B-group sites (451/485), C-group sites (389/383/384), D-group sites (589/67/680), E-group sites (491/493/494/497), and F-group sites (474/478/486/480/484) of several B-family DNA polymerases are analyzed to design the mutant.

## Claims

### Claim 1

A mutant protein, based on a thermostable B-family DNA polymerase and having DNA polymerase activity, wherein the mutant protein is mutated at positions 408, 409 and 485 of an amino acid sequence of the thermostable B-family DNA polymerase.

### Claim 2 (depends on 1)

The mutant protein according to claim 1, wherein the mutant protein having DNA polymerase activity, based on the mutant protein of claim 1, is further mutated at least one amino acid residue at a position(s) selected from positions 451 and 410 in the amino acid sequence of the thermostable B-family DNA polymerase.

### Claim 3 (depends on 1)

The mutant protein according to claim 1, wherein the mutant protein having DNA polymerase activity, based on the mutant of claim 1, is further mutated at least one amino acid residue at a position(s) selected from three positions 383, 384, and 389 in group C in the amino acid sequence of the thermostable B-family DNA polymerase.

### Claim 4 (depends on 1)

The mutant protein according to claim 1, wherein the mutant protein having DNA polymerase activity, based on the mutant of claim 1, is further mutated at least one amino acid residue at a position(s) selected from three positions 589, 676, and 680 in group D in the amino acid sequence of the thermostable B-family DNA polymerase.

### Claim 5 (depends on 1)

The mutant protein according to claim 1, wherein the mutant protein having DNA polymerase activity, based on the mutant of claim 1, is further mutated at least one amino acid residue at a position(s) selected from four positions 491, 493, 494, and 497 in group E in the amino acid sequence of the thermostable B-family DNA polymerase.

### Claim 6 (depends on 2)

The mutant protein according to claim 2, wherein the mutant protein having DNA polymerase activity, based on the mutant of claim 2, is further mutated at least one amino acid residue at a position(s) selected from five positions 474, 478, 480, 484 and 486 in the F group in the amino acid sequence of the thermostable B-family DNA polymerase.

### Claim 7 (depends on 1)

The mutant protein according to claim 1, wherein the mutant protein having DNA polymerase activity, based on the mutant of claim 1, is further mutated an amino acid residue at position 93 in the amino acid sequence of the thermostable B-family DNA polymerase.

### Claim 8 (depends on 1)

The mutant protein according to claim 1, wherein the amino acid at each of the positions 408, 409 and 485 is mutated as follows:
L at position 408 is mutated into A, I or Y;
Y at position 409 is mutated into A; and
E at position 485 is mutated into I or L, or A at position 485 is mutated into L or E or I.

### Claim 9 (depends on 1)

The mutant protein according to claim 1, wherein the thermostable B-family DNA polymerase the mutant protein based on is KOD DNA polymerase, 9° N DNA polymerase, TGO DNA polymerase or TOK DNA polymerase.

### Claim 10 (depends on 9)

The mutant protein according to claim 9, wherein the KOD DNA polymerase is of an amino acid sequence set forth in SEQ ID NO: 1, the 9° N DNA polymerase is of an amino acid sequence set forth in SEQ ID NO: 2, the TGO DNA polymerase is of an amino acid sequence set forth in SEQ ID NO: 3, and the TOK DNA polymerase is of an amino acid sequence set forth in SEQ ID NO: 4.

### Claim 11 (depends on 1)

The mutant protein according to claim 1, wherein the mutant protein is added with a tag sequence at an end of an amino acid sequence of the mutant protein, and has thermostable B-family DNA polymerase activity.

### Claim 12 (depends on 1)

The mutant protein of claim 1 encoded by a DNA molecule, or
an expression cassette, a recombinant vector, a recombinant bacterium or a transgenic cell line comprising the DNA molecule.

### Claim 13 (depends on 1)

A method for at least one of the following i to v by using a mutant protein of claim 1:
i. performing as a DNA polymerase;
ii. catalyzing DNA replication and/or DNA amplification;
iii. nucleic acid sequencing, wherein a specific dNTP with 3′-end blocking modification is introduced during the sequencing;
iv. preparing a product for catalyzing DNA replication and/or DNA amplification; and
v. preparing a product for nucleic acid sequencing, wherein the specific dNTP with 3′-end blocking modification is introduced during the sequencing.

### Claim 14 (depends on 2)

The mutant protein according to claim 2, wherein the amino acid at each of the positions 410 and 451 is mutated as follows:
P at position 410 is mutated into D, C or N; and
S at position 451 is mutated into T or L.

### Claim 15 (depends on 1)

The mutant protein according to claim 1, wherein the amino acid at each of the positions in groups C-F is mutated as follows:
I at position 486 is mutated into R;
D at position 480 is mutated into T or N;
R at position 484 is mutated into C;
I at position 474 is mutated into T or K;
L at position 478 is mutated into I or For R or G or H or C or Y or S;
I at position 474 is mutated into T;
L at position 478 is mutated into I or F;
S at position 383 is mutated into T;
Y at position 384 is mutated to F;
V at position 389 is mutated to I;
V at position 589 is mutated into H;
T at position 676 is mutated into K;
V at position 680 is mutated to M;
A or P at position 491 is mutated into G;
Y at position 493 is mutated to F;
Y at position 494 is mutated to F; and
Y at position 497 is mutated into V or For L.

### Claim 16 (depends on 7)

The mutant protein according to claim 7, wherein the amino acid at position 93 is mutated as follows:
V at position 93 is mutated into Q.

### Claim 17 (depends on 12)

A method for at least one of the following vi to xi by using a DNA molecule, an expression cassette, a recombinant vector, a recombinant bacterium or a transgenic cell line of claim 12:
vi. preparing as a DNA polymerase;
vii. catalyzing DNA replication and/or DNA amplification;
viii. nucleic acid sequencing, wherein a specific dNTP with 3′-end blocking modification is introduced during the sequencing;
ix. preparing a product comprising DNA polymerase;
x. preparing a product for catalyzing DNA replication and/or DNA amplification; and
xi. preparing a product for nucleic acid sequencing, wherein the specific dNTP with 3′-end blocking modification is introduced during the sequencing.
